First-in-Human Single and Multiple Dose of EB8018

NCT02998190 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Single Ascending Doses of EB8018
DRUG: Single Ascending Doses of placebo
DRUG: Multiple Ascending Doses of EB8018
DRUG: Multiple Ascending Doses of placebo

Sponsor

Enterome

Collaborators

[object Object]